Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products -- United States, October 2024-February 2025.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2025, v. 74, n. 16, p. 273, doi. 10.15585/mmwr.mm7416a1
- By:
- Publication type:
- Article